Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled
quick-turn manufacturer, today announced record financial results for
the first quarter ended March 31, 2014.
Highlights include:
-
Revenue for the first quarter of 2014 increased to a record $46.1
million, 23 percent above revenue of $37.3 million in the first
quarter of 2013.
-
The record quarterly revenue was achieved through an 18 percent
increase in the number of product developers served combined with an
increase of 4 percent in spending per product developer.
-
Net income for the first quarter of 2014 increased to a record $10.1
million, or $0.39 per diluted share. Non-GAAP net income, excluding
the after tax expense of stock compensation, was $10.8 million, or
$0.41 per diluted share. See “Non-GAAP Financial Measure” below.
“Our story in the first quarter of 2014 was about execution on many
fronts. We successfully prepared for the formal launches in metal
injection molding and liquid silicone rubber, both of which were
announced the first week of April. Our revenue growth was strong,
especially considering all the weather slow-downs and closures our
customers experienced in the eastern half of the country. And of course,
we completed the acquisition of FineLine Prototyping which we proudly
announced a few days ago,” said Vicki Holt, President and Chief
Executive Officer of Proto Labs.
Additional highlights include:
-
Gross margin was 63.0 percent of revenue in the first quarter of 2014
compared with 62.4 percent during the same quarter in 2013.
-
During the first quarter of 2014, spending on research and
development, including the Protoworks initiatives, totaled $3.5
million, or 7.5 percent of revenue. This compares to $2.6 million, or
7.0 percent of revenue, during the first quarter of 2013.
-
Operating margin was 31.4 percent of revenue during the first quarter
of 2014 compared to 30.5 percent in the first quarter of 2013.
-
As measured on a year-to-date basis, cash generated from operations
totaled $15.3 million and expenditures on capital equipment were $9.9
million. Total cash, cash equivalents and investments totaled $149.9
million as of March 31, 2014.
“As much as we accomplished this past quarter, we expect the next few
quarters will bring even more success. We are confident that our new
services, LSR and MIM, will continue to gain momentum through 2014 and
into 2015 as product developers become aware of and have experience with
these new offerings. The integration of FineLine and its additive
manufacturing service will bring more choices to product developers. We
believe we are building the most dynamic parts supplier in the world
with capabilities to supply our customers’ parts demand from quick-turn
prototyping through short-run volume production via a robust portfolio
of manufacturing technologies in a wide variety of material selections,”
concluded Holt.
Non-GAAP Financial Measure
The company has included non-GAAP net income, adjusted for stock-based
compensation expense, in this press release to provide investors with
additional information regarding the company’s financial results. The
company has provided below a reconciliation of non-GAAP net income,
adjusted for stock-based compensation expense, to net income, the most
directly comparable measure calculated and presented in accordance with
GAAP. Non-GAAP net income, adjusted for stock-based compensation
expense, is used by the company’s management and board of directors to
understand and evaluate operating performance and trends and provides a
useful measure for period-to-period comparisons of the company’s
business. Accordingly, the company believes that non-GAAP net income,
adjusted for stock-based compensation expense, provides useful
information to investors and others in understanding and evaluating
operating results in the same manner as our management and board of
directors.
Conference Call
The company has scheduled a conference call to discuss its first quarter
financial results today, May 1, 2014 at 8:30 a.m. ET. To access the call
in the U.S. please dial 866-700-6067. Outside the U.S. please dial
617-213-8834. Use participant code 17168050. A simultaneous webcast of
the call will also be available on the investor relations section of the
company’s website at www.protolabs.com/investors.
An audio replay will be available for 14 days following the call on the
investor relations section of Proto Labs’ website.
About Proto Labs, Inc.
Proto Labs is a leading online and
technology-enabled quick-turn manufacturer of custom parts for
prototyping and short-run production. Proto Labs provides “Real Parts,
Really Fast” to product developers worldwide. Proto Labs utilizes
computer numerical control (CNC) machining, injection molding, and
additive manufacturing (3D printing), to manufacture custom parts for
our customers. For more information, visit protolabs.com.
Forward-Looking Statements
Statements contained in this
press release regarding matters that are not historical or current facts
are “forward-looking statements” within the meaning of The Private
Securities Litigation Reform Act of 1995. These statements involve known
and unknown risks, uncertainties and other factors which may cause the
results of Proto Labs to be materially different than those expressed or
implied in such statements. Certain of these risk factors and others are
described in the “Risk Factors” section within reports filed with the
SEC. Other unknown or unpredictable factors also could have material
adverse effects on Proto Labs’ future results. The forward-looking
statements included in this press release are made only as of the date
hereof. Proto Labs cannot guarantee future results, levels of activity,
performance or achievements. Accordingly, you should not place undue
reliance on these forward-looking statements. Finally, Proto Labs
expressly disclaims any intent or obligation to update any
forward-looking statements to reflect subsequent events or circumstances.
|
Proto Labs, Inc.
|
Condensed Consolidated Balance Sheets
|
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2014
|
|
|
2013
|
|
|
|
(Unaudited)
|
|
|
|
Assets
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
$
|
44,201
|
|
|
$
|
43,039
|
Short-term marketable securities
|
|
|
|
34,360
|
|
|
|
36,339
|
Accounts receivable, net
|
|
|
|
21,905
|
|
|
|
18,320
|
Inventory
|
|
|
|
5,346
|
|
|
|
5,166
|
Other current assets
|
|
|
|
4,862
|
|
|
|
6,931
|
Total current assets
|
|
|
|
110,674
|
|
|
|
109,795
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
63,963
|
|
|
|
56,101
|
Long-term marketable securities
|
|
|
|
71,315
|
|
|
|
64,023
|
Other long-term assets
|
|
|
|
249
|
|
|
|
256
|
Total assets
|
|
|
$
|
246,201
|
|
|
$
|
230,175
|
|
|
|
|
|
|
|
Liabilities and shareholders' equity
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
Accounts payable
|
|
|
$
|
10,405
|
|
|
$
|
6,455
|
Accrued compensation
|
|
|
|
4,779
|
|
|
|
6,196
|
Accrued liabilities and other
|
|
|
|
1,304
|
|
|
|
808
|
Income taxes payable
|
|
|
|
145
|
|
|
|
-
|
Current portion of long-term debt obligations
|
|
|
|
208
|
|
|
|
204
|
Total current liabilities
|
|
|
|
16,841
|
|
|
|
13,663
|
|
|
|
|
|
|
|
Long-term deferred tax liabilities
|
|
|
|
3,779
|
|
|
|
3,682
|
Long-term debt obligations
|
|
|
|
106
|
|
|
|
159
|
Other long-term liabilities
|
|
|
|
999
|
|
|
|
1,028
|
|
|
|
|
|
|
|
Shareholders' equity
|
|
|
|
224,476
|
|
|
|
211,643
|
Total liabilities and shareholders' equity
|
|
|
$
|
246,201
|
|
|
$
|
230,175
|
|
|
Proto Labs, Inc.
|
Condensed Consolidated Statements of Operations
|
(In thousands, except share and per share amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2014
|
|
|
2013
|
Revenue
|
|
|
|
|
|
|
Protomold
|
|
|
$
|
32,694
|
|
|
$
|
26,880
|
Firstcut
|
|
|
|
13,380
|
|
|
|
10,433
|
Total revenue
|
|
|
|
46,074
|
|
|
|
37,313
|
|
|
|
|
|
|
|
Cost of revenue
|
|
|
|
17,050
|
|
|
|
14,034
|
Gross profit
|
|
|
|
29,024
|
|
|
|
23,279
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
Marketing and sales
|
|
|
|
6,417
|
|
|
|
5,263
|
Research and development
|
|
|
|
3,456
|
|
|
|
2,628
|
General and administrative
|
|
|
|
4,703
|
|
|
|
3,994
|
Total operating expenses
|
|
|
|
14,576
|
|
|
|
11,885
|
Income from operations
|
|
|
|
14,448
|
|
|
|
11,394
|
Other income, net
|
|
|
|
103
|
|
|
|
3
|
Income before income taxes
|
|
|
|
14,551
|
|
|
|
11,397
|
Provision for income taxes
|
|
|
|
4,449
|
|
|
|
3,110
|
Net income
|
|
|
$
|
10,102
|
|
|
$
|
8,287
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.40
|
|
|
$
|
0.33
|
Diluted
|
|
|
$
|
0.39
|
|
|
$
|
0.32
|
|
|
|
|
|
|
|
Shares used to compute net income per share:
|
|
|
|
|
|
|
Basic
|
|
|
|
25,573,851
|
|
|
|
25,014,907
|
Diluted
|
|
|
|
26,091,069
|
|
|
|
25,645,744
|
|
|
Proto Labs, Inc.
|
Condensed Consolidated Statements of Cash Flows
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2014
|
|
|
2013
|
|
|
|
|
|
|
|
Operating activities
|
|
|
|
|
|
|
Net income
|
|
|
$
|
10,102
|
|
|
|
$
|
8,287
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
2,106
|
|
|
|
|
1,734
|
|
Stock-based compensation expense
|
|
|
|
998
|
|
|
|
|
865
|
|
Deferred taxes
|
|
|
|
107
|
|
|
|
|
148
|
|
Excess tax benefit from stock-based compensation
|
|
|
|
(897
|
)
|
|
|
|
(4,067
|
)
|
Amortization of held-to-maturity securities
|
|
|
|
482
|
|
|
|
|
304
|
|
Changes in operating assets and liabilities
|
|
|
|
2,368
|
|
|
|
|
3,874
|
|
Net cash provided by operating activities
|
|
|
|
15,266
|
|
|
|
|
11,145
|
|
|
|
|
|
|
|
|
Investing activities
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
|
(9,892
|
)
|
|
|
|
(2,548
|
)
|
Purchases of marketable securities
|
|
|
|
(32,385
|
)
|
|
|
|
(41,088
|
)
|
Proceeds from maturities of marketable securities
|
|
|
|
26,590
|
|
|
|
|
18,313
|
|
Net cash used in investing activities
|
|
|
|
(15,687
|
)
|
|
|
|
(25,323
|
)
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
|
Payments on debt
|
|
|
|
(50
|
)
|
|
|
|
(92
|
)
|
Proceeds from exercises of stock options and other
|
|
|
|
665
|
|
|
|
|
1,619
|
|
Excess tax benefit from stock-based compensation
|
|
|
|
897
|
|
|
|
|
4,067
|
|
Net cash provided by financing activities
|
|
|
|
1,512
|
|
|
|
|
5,594
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
71
|
|
|
|
|
(246
|
)
|
Net increase (decrease) in cash and cash equivalents
|
|
|
|
1,162
|
|
|
|
|
(8,830
|
)
|
Cash and cash equivalents, beginning of period
|
|
|
|
43,039
|
|
|
|
|
36,759
|
|
Cash and cash equivalents, end of period
|
|
|
$
|
44,201
|
|
|
|
$
|
27,929
|
|
|
|
Proto Labs, Inc.
|
Reconciliation of GAAP to Non-GAAP Financial Measure
|
(In thousands, except share and per share amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31, 2014
|
Non-GAAP net income, adjusted for stock-based compensation expense:
|
|
|
|
GAAP net income
|
|
|
$
|
10,102
|
|
Add back: Stock-based compensation expense
|
|
|
|
Cost of revenue
|
|
|
|
82
|
|
Marketing and sales
|
|
|
|
195
|
|
Research and development
|
|
|
|
215
|
|
General and administrative
|
|
|
|
506
|
|
Total stock-based compensation expense
|
|
|
|
998
|
|
Income tax benefits on stock-based compensation
|
|
|
|
(312
|
)
|
Non-GAAP net income
|
|
|
$
|
10,788
|
|
|
|
|
|
Non-GAAP net income per share:
|
|
|
|
Basic
|
|
|
$
|
0.42
|
|
Diluted
|
|
|
$
|
0.41
|
|
|
|
|
|
Shares used to compute non-GAAP net income per share:
|
|
|
|
Basic
|
|
|
|
25,573,851
|
|
Diluted
|
|
|
|
26,091,069
|
|
|
|
Proto Labs, Inc.
|
Revenue by Geography - Based on Shipping Location
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2014
|
|
|
2013
|
Revenues
|
|
|
|
|
|
|
Domestic
|
|
|
|
|
|
|
United States
|
|
|
$
|
33,022
|
|
|
$
|
28,148
|
International
|
|
|
|
|
|
|
Europe
|
|
|
|
9,205
|
|
|
|
6,465
|
Japan
|
|
|
|
1,885
|
|
|
|
1,349
|
United States
|
|
|
|
1,962
|
|
|
|
1,351
|
Total international
|
|
|
|
13,052
|
|
|
|
9,165
|
Total revenue
|
|
|
$
|
46,074
|
|
|
$
|
37,313
|
|
|
Proto Labs, Inc.
|
Customer Information
|
(In thousands, except customer amounts)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
|
2014
|
|
|
2013
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Customers
|
|
|
Revenue ($)
|
|
|
Customers
|
|
|
Revenue ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New customers
|
|
|
559
|
|
|
$
|
3,196
|
|
|
710
|
|
|
$
|
3,078
|
Existing customers
|
|
|
4,325
|
|
|
|
42,878
|
|
|
3,528
|
|
|
|
34,235
|
Total
|
|
|
4,884
|
|
|
$
|
46,074
|
|
|
4,238
|
|
|
$
|
37,313
|
|
|
Proto Labs, Inc.
|
Product Developer Information
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2014
|
|
|
2013
|
|
|
|
|
|
|
|
Unique product developers served
|
|
|
7,669
|
|
|
6,488
|
|
Copyright Business Wire 2014